Commentary Goblet cell autoantibodies in patients with inflammatory bowel diseasesMaria G. Mytilinaiou, Andreas L. Koutsoumpas, Dimitrios P. Bogdanos
Commentary Autoantibodies as prognosticators of treatment outcome in cancerous diseases: learning from immune-check point inhibitorsVasileios Papadopoulos, Eleni Patrikiou, Christos Liaskos, Christina Tsigalou, Dimitrios P. Bogdanos